Aptose Biosciences (APTO) announced that Nasdaq has granted the company’s request for an extension to evidence compliance with all applicable criteria for continued listing on Nasdaq.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APTO: